A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared with Placebo in Adults with Attention Deficit/Hyperactivity Disorder (ADHD)
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Alcobra Ltd.
Start Date
April 1, 2014
End Date
March 31, 2015
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Alcobra Ltd.
Start Date
April 1, 2014
End Date
March 31, 2015